Patents Assigned to LEVATION PHARMA LTD.
  • Compositions and uses of alpha-adrenergic agents
    Patent number: 11491104
    Abstract: The disclosure provides cosmetic and therapeutic compositions of alpha-adrenergic agents. Compositions of the disclosure may be used for topical, transdermal or parenteral administration to the eye or eyelid. The compositions of the disclosure may be used cosmetically to improve the appearance of the eye or therapeutically to treat ptosis.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: November 8, 2022
    Assignee: LEVATION PHARMA LTD.
    Inventors: Frank Litvack, Houman Hemmati
  • Compositions and uses of alpha-adrenergic agents
    Patent number: 11311476
    Abstract: The disclosure provides cosmetic and therapeutic compositions of alpha-adrenergic agents. Compositions of the disclosure may be used for topical, transdermal or parenteral administration to the eye or eyelid. The compositions of the disclosure may be used cosmetically to improve the appearance of the eye or therapeutically to treat ptosis.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: April 26, 2022
    Assignee: Levation Pharma Ltd.
    Inventors: Frank Litvack, Houman Hemmati
  • Compositions and uses of alpha-adrenergic agents
    Patent number: 10828252
    Abstract: The disclosure provides cosmetic and therapeutic compositions of alpha-adrenergic agents. Compositions of the disclosure may be used for topical, transdermal or parenteral administration to the eye or eyelid. The compositions of the disclosure may be used cosmetically to improve the appearance of the eye or therapeutically to treat ptosis.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: November 10, 2020
    Assignee: LEVATION PHARMA LTD.
    Inventors: Frank Litvack, Houman Hemmati